Shares of Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) crossed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $19.03 and traded as high as $20.85. Shionogi & Co., Ltd. shares last traded at $20.85, with a volume of 100 shares changing hands.
Shionogi & Co., Ltd. Stock Performance
The firm’s 50 day moving average is $17.88 and its 200 day moving average is $19.04.
Shionogi & Co., Ltd. Company Profile
Shionogi & Co, Ltd. is a Japanese pharmaceutical company headquartered in Osaka. Founded in 1878, the company researches, develops, manufactures and markets prescription medicines, with a focus on addressing infectious diseases and other significant unmet medical needs.
Its portfolio and development programs have included treatments for infectious diseases, central nervous system conditions, pain and other therapeutic areas. Shionogi is known for products such as Xofluza (baloxavir marboxil), an influenza treatment, and Fetroja (cefiderocol), an antibiotic for certain difficult-to-treat bacterial infections.
Read More
- Five stocks we like better than Shionogi & Co., Ltd.
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
